Investors could be missing key elements of the AMZN stock narrative, including AI and Pharmacy
With Michael Saylor driving the MSTR stock engine, there may be no stopping the crypto train
Gone are the days where an an investor could cherry-pick stocks like Bird Construction, Docebo and Versabank
Happy U.S. customers and a competing CEO who's a lightening rod for political passions contribute to the RIVN stock narrative
Our latest names pull from the actively managed TD Canadian Small-Cap Equity Fund
There’s still a potential SAVA stock play despite the heavy skepticism
The wait for a Federal loan commitment hangs over the shares in the near term
Reaching the halfway point of TSX, TSX Venture names in coverage
The risk-reward ratio for DRUG stock is simply too negative
As Canada's CEOs mull what to expect under Trump, contributor Will Ashworth continues to build his north-of-the-border coverage universe
With a likely push to make oil great again, XOM stock should benefit handsomely
The incoming Trump administration could put a congested U.S. electrical grid among its top priorities
